Enrique Bellolio

Enrique Bellolio

Auto-generated profile, based on publicly available information

Enrique Bellolio

Department of Pathological Anatomy, School of Medicine Universidad de La Frontera Temuco Chile

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2020 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
ZKZuzana Kos
Zuzana Kos
ERElvire Roblin
Elvire Roblin
RKRim S. Kim
Rim S. Kim
SMStefan Michiels
Stefan Michiels
BGBrandon D. Gallas
Brandon D. Gallas
RSRoberto Salgado
Roberto Salgado
Stromal tumor-infiltrating lymphocytes (sTILs) are important prognostic and predictive biomarkers in triple-negative (TNBC) and HER2-positive breast cancer. Incorporating sTILs into clinical practice necessitates reproducible assessment. Previously developed standardized scoring guidelines have been widely embraced by the clinical and research communities. We evaluated sources of variability in sTIL assessment by pathologists in three previous sTIL ring studies. We identify common challenges and evaluate impact of discrepancies on outcome estimates in early TNBC using a newly-developed prognostic tool. Discordant sTIL assessment is driven by heterogeneity in lymphocyte distribution. Additional factors include: technical slide-related issues; scoring outside the tumor boundary; tumors with minimal assessable stroma; including lymphocytes associated with other structures; and including other inflammatory cells. Small variations in sTIL assessment modestly alter risk estimation in early TNBC but have the potential to affect treatment selection if cutpoints are employed. Scoring and averaging multiple areas, as well as use of reference images, improve consistency of sTIL evaluation. Moreover, to assist in avoiding the pitfalls identified in this analysis, we developed an educational resource available at www.tilsinbreastcancer.org/pitfalls.

21 July 2018 in Human Pathology
Verified
Journal Article
Open access
Jill KoshiolJill Koshiol
Jill Koshiol
EBEnrique Bellolio
Enrique Bellolio
CVCarolina Vivallo
Carolina Vivallo
PCPaz Cook
Paz Cook
Juan Carlos RoaJuan Carlos Roa
Juan Carlos Roa
JAJuan Carlos Araya
Juan Carlos Araya
Gallbladder dysplasia can progress to cancer and may be associated with increased cancer risk at other biliary tract sites. Thus, its accurate identification is relevant both for etiologic understanding and for clinical purposes. Data on the frequency and distribution of gallbladder dysplasia are lacking owing to limited gallbladder sampling and inability to visualize dysplasia grossly. An expert pathology group used consensus criteria to review 140 totally sampled consecutive cholecystectomy specimens from Chilean women. Three cases (2%) revealed incidental invasive carcinoma, all T2, along with high-grade dysplasia (HGD). The surface areas covered by dysplasia or cancer in these cases were 9%, 37%, and 87%. Although the first longitudinal ("diagnostic") section of the whole gallbladder captured HGD or cancer in all 3 cases, the deepest focus of invasive carcinoma was not present in this section. Fourteen additional cases (10%) had low-grade dysplasia (LGD), which was typically very focal (covering <5% of the surface) and most often occurred in the fundus. LGD was not present in the diagnostic section of 5 cases (38%) and would have been missed without additional sampling. None of the cancers or dysplasias were grossly visible. Although HGD and carcinoma are likely to be identified in "diagnostic" sections, accurate staging requires total sampling. LGD is typically very focal and would often be missed in routine practice. To identify cancer precursors, additional sampling, particularly of the fundus, may be warranted. The predominance of LGD in the fundus also provides etiologic insight, supporting the contribution of gallstones and chronic inflammation.

8 May 2025 in Experimental Dermatology
Verified
Journal Article
Closed access
FSFabiola Schafer
Fabiola Schafer
EBEnrique Bellolio
Enrique Bellolio
TSTatiana Sepúlveda
Tatiana Sepúlveda
MEMirta Espinoza
Mirta Espinoza
JOJuan‐José Orellana
Juan‐José Orellana
RMRodrigo Miranda
Rodrigo Miranda

31 December 2024 in Cardiology Journal
Verified
Journal Article
Open access
PDF file
FSFabiola Schafer
Fabiola Schafer
MTMarcos Tapia
Marcos Tapia
EBEnrique Bellolio
Enrique Bellolio
RMRodrigo Miranda
Rodrigo Miranda